WA
MRNA icon

WPG Advisers’s Moderna MRNA Stock Holding History

WPG Advisers’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05K Hold
15
– – ﹤0.01% 1319
2026
Q1 		$762 Hold
15
– – ﹤0.01% 1305
2025
Q4 		$442 Hold
15
– – ﹤0.01% 1395
2025
Q3 		$387 Hold
15
– – ﹤0.01% 1391
2025
Q2 		$414 Hold
15
– – ﹤0.01% 1365
2025
Q1 		$425 Hold
15
– – ﹤0.01% 1364
2024
Q4 		$624 Buy
+15
New +$717 ﹤0.01% 1303

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

WPG Advisers's MRNA Position: Q2 2026 in Review

WPG Advisers held its Moderna (MRNA) position steady in Q2 2026 at 15 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #1319.

WPG Advisers first reported a position in MRNA in Q4 2024 and has held it in 7 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • WPG Advisers held 15 shares of Moderna worth $1.05K as of Q2 2026.
  • WPG Advisers left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of WPG Advisers's portfolio in Q2 2026, its #1319 holding.
  • WPG Advisers first reported a position in Moderna in Q4 2024 and has held it in 7 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.